These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38548338)

  • 1. KSR1 Knockout Mouse Model Demonstrates MAPK Pathway's Key Role in Cisplatin- and Noise-induced Hearing Loss.
    Ingersoll MA; Lutze RD; Kelmann RG; Kresock DF; Marsh JD; Quevedo RV; Zuo J; Teitz T
    J Neurosci; 2024 May; 44(18):. PubMed ID: 38548338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KSR1 knockout mouse model demonstrates MAPK pathway's key role in cisplatin- and noise-induced hearing loss.
    Ingersoll MA; Lutze RD; Kelmann RG; Kresock DF; Marsh JD; Quevedo RV; Zuo J; Teitz T
    bioRxiv; 2023 Nov; ():. PubMed ID: 38014104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDA-Approved MEK1/2 Inhibitor, Trametinib, Protects Mice from Cisplatin and Noise-Induced Hearing Loss.
    Lutze RD; Ingersoll MA; Kelmann RG; Teitz T
    bioRxiv; 2024 May; ():. PubMed ID: 38826449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trametinib, a MEK1/2 Inhibitor, Protects Mice from Cisplatin- and Noise-Induced Hearing Loss.
    Lutze RD; Ingersoll MA; Kelmann RG; Teitz T
    Pharmaceuticals (Basel); 2024 Jun; 17(6):. PubMed ID: 38931403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ERK1/2 Inhibition Alleviates Noise-Induced Hearing Loss While Tempering Down the Immune Response.
    Lutze RD; Ingersoll MA; Thotam A; Joseph A; Fernandes J; Teitz T
    bioRxiv; 2023 Oct; ():. PubMed ID: 37905140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ERK1/2 Inhibition via the Oral Administration of Tizaterkib Alleviates Noise-Induced Hearing Loss While Tempering down the Immune Response.
    Lutze RD; Ingersoll MA; Thotam A; Joseph A; Fernandes J; Teitz T
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of kinase suppressor of Ras1 enhances cisplatin-induced extracellular signal-regulated kinase activation and cisplatin sensitivity.
    Kim M; Yan Y; Kortum RL; Stoeger SM; Sgagias MK; Lee K; Lewis RE; Cowan KH
    Cancer Res; 2005 May; 65(10):3986-92. PubMed ID: 15899786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficiency of kinase suppressor of Ras1 prevents oncogenic ras signaling in mice.
    Lozano J; Xing R; Cai Z; Jensen HL; Trempus C; Mark W; Cannon R; Kolesnick R
    Cancer Res; 2003 Jul; 63(14):4232-8. PubMed ID: 12874031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of Ras/Mapk pathway signaling inhibits Myc-induced lymphomagenesis.
    Gramling MW; Eischen CM
    Cell Death Differ; 2012 Jul; 19(7):1220-7. PubMed ID: 22301919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dabrafenib protects from cisplatin-induced hearing loss in a clinically relevant mouse model.
    Ingersoll MA; Lutze RD; Pushpan CK; Kelmann RG; Liu H; May MT; Hunter WJ; He DZ; Teitz T
    JCI Insight; 2023 Dec; 8(24):. PubMed ID: 37934596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nox3-Derived Superoxide in Cochleae Induces Sensorineural Hearing Loss.
    Mohri H; Ninoyu Y; Sakaguchi H; Hirano S; Saito N; Ueyama T
    J Neurosci; 2021 May; 41(21):4716-4731. PubMed ID: 33849947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compartmentalization of the MAPK scaffold protein KSR1 modulates synaptic plasticity in hippocampal neurons.
    Canal F; Palygin O; Pankratov Y; Corrêa SA; Müller J
    FASEB J; 2011 Jul; 25(7):2362-72. PubMed ID: 21471251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KSR1 is a functional protein kinase capable of serine autophosphorylation and direct phosphorylation of MEK1.
    Goettel JA; Liang D; Hilliard VC; Edelblum KL; Broadus MR; Gould KL; Hanks SK; Polk DB
    Exp Cell Res; 2011 Feb; 317(4):452-63. PubMed ID: 21144847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRAF inhibition protects against hearing loss in mice.
    Ingersoll MA; Malloy EA; Caster LE; Holland EM; Xu Z; Zallocchi M; Currier D; Liu H; He DZZ; Min J; Chen T; Zuo J; Teitz T
    Sci Adv; 2020 Dec; 6(49):. PubMed ID: 33268358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calmodulin influences MAPK signaling by binding KSR1.
    Parvathaneni S; Li Z; Sacks DB
    J Biol Chem; 2021; 296():100577. PubMed ID: 33766558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ginkgo biloba extract enhances chemotherapy sensitivity and reverses chemoresistance through suppression of the KSR1-mediated ERK1/2 pathway in gastric cancer cells.
    Liu SQ; Xu CY; Qin MB; Tan L; Zhuge CF; Mao YB; Lai MY; Huang JA
    Oncol Rep; 2015 Jun; 33(6):2871-82. PubMed ID: 25962735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caspase-dependent cleavage disrupts the ERK cascade scaffolding function of KSR1.
    McKay MM; Morrison DK
    J Biol Chem; 2007 Sep; 282(36):26225-34. PubMed ID: 17613518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KSR1 is required for cell cycle reinitiation following DNA damage.
    Razidlo GL; Johnson HJ; Stoeger SM; Cowan KH; Bessho T; Lewis RE
    J Biol Chem; 2009 Mar; 284(11):6705-15. PubMed ID: 19147494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyr728 in the kinase domain of the murine kinase suppressor of RAS 1 regulates binding and activation of the mitogen-activated protein kinase kinase.
    Sibilski C; Mueller T; Kollipara L; Zahedi RP; Rapp UR; Rudel T; Baljuls A
    J Biol Chem; 2013 Dec; 288(49):35237-52. PubMed ID: 24158441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation regulates KSR1 stability, ERK activation, and cell proliferation.
    Razidlo GL; Kortum RL; Haferbier JL; Lewis RE
    J Biol Chem; 2004 Nov; 279(46):47808-14. PubMed ID: 15371409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.